Metabolic syndrome (MetS) as a global public health problem is a complex constellation of metabolic abnormalities including hypertension, elevated triglycerides, decreased high-density lipoprotein (HDL), hyperglycemia and central obesity (
1). Metabolic syndrome, also known as syndrome X (
2), is associated with 3 fold and 2 fold increases in type 2 diabetes mellitus and cardiovascular disease, respectively (
3). Cardiovascular diseases are among the main causes of mortality in Iran (
4). Several definitions, using different criteria for MetS have been proposed since 1998 (
5). The first definition was released by the world health organization (WHO) based on laboratory measurement of insulin resistance and the existence of two components of the following risk factors: low-density lipoprotein (LDL) cholesterol, obesity, high blood pressure and elevated triglycerides. The third adult treatment panel (ATP III) defined the syndrome based on the presence of 3 of 5 criteria including LDL and HDL levels, fasting hyperglycemia, hypertension, hypertriglyceridemia and central obesity with an emphasis on cardiovascular hazards. Central obesity was defined as a WC of more than 102 and 88 for men and women, respectively. International diabetes federation (IDF) generated new definition and decreased cut-off values for WC to 94 and 80 for men and women, respectively (
6,
7).
The Iranian National Committee of Obesity (INCO) survey found that a WC cut-off point of 90 cm is a predictor of MetS in both genders (
8). Central obesity, as assessed by WC, based on IDF and national cholesterol education program’s adult treatment (NCEP III) definitions, is an important component of MetS (
6,
7). Determination of cut-off points for WC is accepted as the best anthropometric indicator of abdominal adiposity, which reflects increased abdominal fat or visceral fat, which has an essential role in pathogenesis of MetS (
9-
14). Waist circumference has been shown to be more correlated with MetS components better than fat percentage (
15).
So much evidence shows a link between WC and other criteria of MetS and cardiovascular disease (
16). Waist circumference is a simple valid, cost effective clinical anthropometric measure predictor for detection of MetS (
9-
18). The use of WC is preferred to BMI for evaluation of abdominal adiposity (
19), but the cut-off values of WC vary according to ethnicity, gender and lifestyle; therefore, population-specific cutoff points were incorporated into the definition (
6,
20).